arrow
C

Carlos King Ho Wong

London School of Hygiene and Tropical Medicine
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ten-Year Cost-Effectiveness of the Risk Assessment and Management Programme—Diabetes Mellitus (RAMP-DM) Relative to Usual Care in Hong Kong Public Primary Care: A Population-Based Cohort Study

香港公立初级保健中风险评估和管理计划—糖尿病 mellitus(RAMP-DM)相对于常规护理的十年成本效益:一项基于人群的队列研究

2026-08-280
OAAI
P82 - ECE_2073 - Parathyroidectomy and risk of diabetes progression in primary hyperparathyroidism patients comorbid with diabetes: a target trial emulation in a population-based cohort

P82 - ECE_2073 - 原发性甲状旁腺功能亢进伴糖尿病患者行甲状旁腺切除术后糖尿病进展风险:一项基于人群队列的目标试验模拟研究

2026-08-100
OAAI
Development and validation of age-specific predictive models on the risk of post-acute mortality within 1 year of COVID-19 infection

基于COVID-19感染后1年内急性期后死亡风险的年龄特异性预测模型的开发与验证

2025-12-010
OA
Antibiotic stewardship in suspected neutropenic fever (ASTERIC trial): a multicentre, type 1 hybrid effectiveness-implementation, stepped-wedge, randomised controlled trial study protocol

抗菌药物合理使用在疑似中性粒细胞减少性发热中的应用(ASTERIC试验):一项多中心、I型混合效果-实施、阶梯式楔形随机对照试验研究方案

2025-11-240
OA
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

Nirmatrelvir-ritonavir立即开始治疗对COVID后结果的更大益处: 一项基于人群的回顾性队列研究

2025-11-100
OAAI
Post-COVID-19 multimorbidity incidence by prior vaccination status in people with a pre-existing comorbidity: A population-based cohort study

后COVID-19时期,在存在预存合并症的人群中,根据既往疫苗接种状态分析多病共存发生率:一项基于人群的队列研究

2025-08-210
OAAI
Developing a named entity framework for thyroid cancer staging and risk level classification using large language models

基于大型语言模型开发用于甲状腺癌分期和风险水平分类的命名实体框架

2025-03-011
OA
Incidence of Deliberate Self-Harm in Hong Kong Before and During the COVID-19 Pandemic: Population-Wide Retrospective Cohort Study

新型冠状病毒肺炎大流行之前和期间香港自伤的发病率: 全人群回顾性队列研究

2025-02-100
OAAI
High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis

在缺乏分子检测的情况下,不确定的甲状腺结节的不必要手术率高,以及在亚洲人群中使用分子检测的成本效益: 决策分析

THYROID
IF6.7
2025-02-010
PRE
Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID-19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta-Analysis

抗病毒药物和单克隆抗体治疗感染Omicron变体的新型冠状病毒肺炎患者的比较有效性: 系统评价和网络荟萃分析

2024-12-250
OA
The association of HDL-cholesterol levels with incident major adverse cardiovascular events and mortality in 0.6 million individuals with type 2 diabetes: a population-based retrospective cohort study

60万2型糖尿病患者HDL-胆固醇水平与主要不良心血管事件和死亡率的关系: 一项基于人群的回顾性队列研究

2024-12-181
OAAI